Ertaczo Topical Antifungal Will Face Stiff OTC Competition
This article was originally published in The Tan Sheet
Executive Summary
OrthoNeutrogena's newly approved topical athlete's foot treatment Ertaczo will face an uphill marketing battle from a slew of OTC antifungals indicated for ringworm and jock itch
You may also be interested in...
Lotrimin Ultra Antifungal Switch Approved By FDA
Schering-Plough's Lotrimin Ultra will launch nationwide in the first quarter of 2002, marking the third generation of OTC athlete's foot antifungals to bear the Lotrimin name
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands